Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 697

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 697
---
938 |   |

453

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

| (1) | TuHURA Biosciences, Inc. - Net loss attributable to common stockholders per share includes the related pro forma adjustments as referred to within the section “Unaudited Pro Forma Condensed Combined Financial Information.” |

| (2) | The potentially dilutive outstanding securities were excluded from the computation of the TuHURA Biosciences, Inc. - Net loss attributable to common stockholders per share, basic and diluted, because their effect would have been anti-dilutive and/or issuance or vesting of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the periods presented. |

The following table presents a roll-forward of the shares issued and assumed to be issued following the consummation of the Kintara Merger and the transactions leading up to the Closing of the Mergers:

|                                                                       |     | Common Shares Issued or 
 Assumed to be Issued    |            |
| TuHURA Biosciences, Inc. weighted average shares after Kintara Merger |     |                         | 42,284,525 |
| Shares issued as purchase consideration in Mergers                    |     |                         |  3,868,635 |
| Shares issued in connection with the Concurrent Investment            |     |                         |  4,952,579 |
| Shares issued for TuHURA Warrant Exercises(1)                         |     |                         |  1,395,871 |
| Shares underlying Penny Warrants issued(2)                            |     |                         |    297,029 |
| Pro Forma weighted average shares outstanding                         |     |                         | 52,798,639 |

| (1) | The aggregate amount of shares issued in connection with TuHURA Warrants exercised following the closing of the Kintara Merger, consisting of 39,234 exercises which occurred prior to December 31, 2024, with the underlying shares issued already reflected in the TuHURA historical financial statements as of December 31, 2024, and 1,356,637 additional exercises that have occurred subsequent to December 31, 2024 |

| (2) | Penny Warrants assumed to be exercised and converted into shares of TuHURA Common Stock as soon as they were exercisable based on the nominal exercise price of $0.01 per share |

Net loss